Home/Filings/4/0001610717-25-000049
4//SEC Filing

Saxonov Serge 4

Accession 0001610717-25-000049

CIK 0001770787other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:50 PM ET

Size

12.3 KB

Accession

0001610717-25-000049

Insider Transaction Report

Form 4
Period: 2025-02-28
Saxonov Serge
DirectorChief Executive Officer
Transactions
  • Sale

    Class A Common Stock

    2025-02-28$10.63/sh7,942$84,393871,540 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-03-0450,00017,463 total
    Exercise: $1.20Exp: 2027-10-18Class A Common Stock (50,000 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-03-04$1.20/sh+50,000$60,000921,540 total
Holdings
  • Class A Common Stock

    (indirect: See footnote)
    27
  • Class A Common Stock

    (indirect: See footnote)
    22,570
  • Class A Common Stock

    (indirect: See footnote)
    870
  • Class A Common Stock

    (indirect: See footnote)
    213,250
Footnotes (7)
  • [F1]The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 12, 2024 and terminated effective March 4, 2025.
  • [F2]This transaction was executed in multiple trades at prices ranging from $10.415 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F3]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
  • [F4]The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
  • [F5]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
  • [F6]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
  • [F7]This option, originally for 300,000 shares, of which 282,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021.

Documents

1 file

Issuer

10x Genomics, Inc.

CIK 0001770787

Entity typeother

Related Parties

1
  • filerCIK 0001786720

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:50 PM ET
Size
12.3 KB